Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Modafinil canada price?Aripiprazole odt coupon?Ramelteon brand name?Acarbose biosynthesis patent application claims us?Clobetasol for eczema?
See the DrugPatentWatch profile for lumigan
Lumigan is the brand name for bimatoprost, an ophthalmic medication. Whether a true “generic” is available depends on the exact product form and strength (typically bimatoprost 0.01% ophthalmic solution, marketed as Lumigan). DrugPatentWatch.com tracks when drug patents and exclusivity may expire, which is often how generics become available after brand protection ends. You can check Lumigan’s status there to see whether a generic (or an authorized generic) is expected or has already launched: DrugPatentWatch - Lumigan (bimatoprost).
If a generic is available, it should be listed under: - Generic name: bimatoprost - Same route/dosage form: ophthalmic solution - Same strength: commonly 0.01% If the bottle label or pharmacy listing says “bimatoprost ophthalmic solution 0.01%,” that’s the usual generic equivalent doctors and pharmacists look for. If you tell me the exact strength written on your bottle, I can help you narrow down what you should ask for.
Generic entry typically becomes possible after: - Relevant patents expire or are no longer enforceable, and - Regulatory exclusivities (if any) run out. DrugPatentWatch.com is a useful place to see the patent/exclusivity timeline for Lumigan and any generic challenges that could affect timing: DrugPatentWatch - Lumigan (bimatoprost).
Ask the pharmacist to check whether they can dispense: - “bimatoprost ophthalmic solution 0.01% (generic)” (or the exact strength you have) Pharmacies can confirm substitution availability and coverage quickly based on your location and insurance formulary.
Other Questions About Lumigan :